Observational Cohort Study of Chronic Viral Infection in the Central Nervous System

Recruiting Observational Study
Progressive Multifocal Leukoencephalopathy Immune Checkpoint Inhibitors
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
14 and older
Sex
Any
Study type
Observational
Participants needed
66 (estimated)
Sponsor
Peking Union Medical College Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This research team intends to conduct a real-world cohort study of chronic CNS viral infections represented by PML, to evaluate whether administration of immune checkpoint inhibitors improves long-term outcomes in this patient population.Patients with prior follow-up will be enrolled into a retrospective/prospective ambidirectional cohort, and newly diagnosed patients will be enrolled into a prosp…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age \> 14 years old. 2. Confirmed diagnosis of chronic viral infection of the central nervous system (CNS). 3. Signed informed consent. The diagnosis of Progressive Multifocal Leukoencephalopathy (PML) shall meet one of the following criteria:(1) Neuropathological diagnosis: …
Contacts

Siyuan Fan

+86 13426341726

siyuanfan@outlook.com

CONTACT